8
Oct
2024
MUP Medical Union Pharmaceuticals
Exhibitor at CPHI Milan 2024 stand 14F28, Finished Dosage Formulations
About Us
Categories
-
EG
-
2020On CPHI since
-
1000 - 4999Employees
Event information
CPHI Milan 2024
-
08 Oct 2024 - 10 Oct 2024
-
Fiera Milano, Italy
-
Visit us at stand 14F28, Finished Dosage Formulations
Products Featured at CPHI Milan 2024
-
Product Insulinaegypt
Active ingredient: Insulin human injection
Indication: Hypoglycemic Agent
Forms: Vails & Cartilages
Doses: Insulinagypt N 100 IU
Insulinagypt R 100 IU ... -
Product Davalindi Tablet
Active ingredient: 10 mg Cholecalciferol Concetrate (100.00 IU/g) equivalent to (1000 IU) cholecalciferol (vit. D3)
Indication: Vit. D3 supplement, treatment of rickets and osteoporosis
Forms: Tablet
Pack Size: 100 tab -
Product Dexamethasone
Active ingredient: 8 mg Dexamethasone Phosphat / 2 ml Amp.
Indication: Systemic Corticosteroid
Forms: Ampoule -
Product Levanic
Active ingredient: Levofluxacin
Indication: Broad-Spectrum Antibiotic ( Quinolone Group )
Forms: Levanic 500 mg Tablet
Levanic 750 mg Tablet -
Product Mobitil
Active ingredient: Meloxicam
Indication: Non steroidal Anti-inflammatory, analgesic
Forms: Tab, Amp and suppositories
Doses: Mobitil 15 mg Supp, Mobitil 7.5mg Tab, Mobitil 15 mg Tab, Mobitil 15 mg Ampoule
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance